Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality: Striving for Efficiency, Equity and Quality
The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care. Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers.
Τι λένε οι χρήστες - Σύνταξη κριτικής
Δεν εντοπίσαμε κριτικές στις συνήθεις τοποθεσίες.
Chapter 2 The politics of pharmaceuticals in the European Union
Chapter 4 The role of the EMEA in regulating pharmaceutical products
Chapter 5 Measuring monitoring and evaluating policy outcomes in the pharmaceutical sector
Chapter 6 Regulating pharmaceutical prices in the European Union
Chapter 7 Reimbursement of pharmaceuticals in the European Union
Chapter 8 Good prescribing practice
Chapter 13 Influencing demand for drugs through cost sharing
Chapter 14 The offpatent pharmaceutical market
Chapter 15 The overthecounter pharmaceutical market
Chapter 16 The implications of pharmacogenetics and pharmacogenomics for drug development and health care
Chapter 17 Should we pay for lifestyle drugs?
Chapter 18 Alternative medicines in Europe
Chapter 19 The pharmaceutical sector and regulation in the countries of Central and Eastern Europe
Chapter 20 Access to pharmaceuticals and regulation in the Commonwealth of Independent States
Chapter 9 Patients and their medicines
Chapter 10 Financial incentives and prescribing
Chapter 11 Regulating pharmaceutical distribution and retail pharmacy in Europe
Chapter 12 Hospital pharmacies
Άλλες εκδόσεις - Προβολή όλων
Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And ...
Mossialos, Elias,Mrazek, Monique,Walley, Tom
Περιορισμένη προεπισκόπηση - 2004
adverse drug reactions alternative medicines assessment beneﬁt British Medical Journal budgets cent ceutical Chapter clinical companies competition cost sharing cost-effectiveness CPMP decisions deﬁned deﬁnition difﬁcult disease dispensing doctors economic evaluation effective efﬁcacy efﬁciency EMEA Europe European Commission European Parliament European Union ﬁnancial incentives ﬁrms ﬁrst formulary France fundholding funds Germany groups guidelines Health Care Systems Health Policy health services hospital pharmacy impact improve increase individual inﬂuence issues lifestyle drugs manufacturers marketing authorization medicinal products Mossialos Netherlands NPr NPr NPr Observatory on Health off-patent Ofﬁce outcomes parallel imports patients pharma pharmaceutical expenditure pharmaceutical industry pharmaceutical market pharmaceutical prices pharmaceutical sector pharmacists pharmacogenetic pharmacovigilance physicians practice prescribing prescription charges prescription drugs proﬁt public health reference pricing reﬂect regulation regulatory reimbursement role scheme scientiﬁc signiﬁcant speciﬁc studies therapeutic therapy tion treatment wholesalers World Health Organization